English
Język Polski
A financial perspective on the pharmaceutical industry
Yunus Emre Kahraman
Yılmaz Çalışkan
Abstrakt
As a result of the epidemics in the world in recent years the importance of the health sector has once again emerged and countries have started to invest more in the health sector. In addition to developed countries, underdeveloped and developing countries are investing more in the health sector and technology and governments are trying to control increasing health expenditures. One of the important and dynamic sub-sectors of the health sector is the pharmaceutical sector. States and international companies are investing more in the pharmaceutical sector in order to combat the epidemics in recent years and are conducting more R&D studies by utilizing the developing technology. In this study in the light of the data published by the OECD, it is examined whether there is a similar relationship between the change in the share of health expenditures in the GNP (Gross National Product) of OECD countries between 2010 and 2022 and the change in the size of the pharmaceutical sector in OECD countries. The change in the size of the pharmaceutical sector and the change in the share of health expenditures in GNP have not yielded similar results in each OECD country. It is thought that different factors such as demographic characteristics, geographical location and economic conditions of countries should be taken into consideration when evaluating the relationship between these two variables.
Podobne artykuły
- Aleksandra Białczyk, Gabriela Leśniak, Filip Nadolny, Justyna Mrowiec, Antoni Otałęga, Odkrywanie horyzontów cyfrowego zdrowia: przegląd innowacji w dziedzinie e-zdrowia w Polsce, Hiszpanii, Rumunii i Estonii. , Prospects in Pharmaceutical Sciences: Tom 22 Nr 1 (2024)
- Magdalena Makarewicz, Anna Łysiak, Katarzyna Łysiak, Barbara Maziarz, Evaluation of the effectiveness of platelet-rich plasma therapy in the treatment of osteoarthritis compared to other treatment methods , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)
- Katarzyna Łysiak, Anna Łysiak, The role of the gut microbiome in Alzheimer's disease , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)
- Maciej Bara, Jakub Starownik, Jakub Szydło, Patryk Gryszkiewicz, Jakub Nieznański, Dapagliflozin - new solution in chronic kidney disease treatment , Prospects in Pharmaceutical Sciences: Tom 22 Nr 2 (2024)
- Ewelina Flegiel, english English, English English, English English, English English, English English, English English, English English, English English, English English, English , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)
- Katarzyna Łysiak, Anna Łysiak, Barbara Maziarz, Paulina Przywara, Natalia Bogumiłło, Julia Ignacak, Kinga Ściurka, Mikołaj Borek, Oliwia Grzelak, Insomnia in the elderly and contemporary treatment methods , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)
- Dominika Winiarz, Kamila Domańska, Kinga Paluch, Dorota Dorota Skrajnowska, PROBIOTYKI A ZDROWIE - DZIŚ I JUTRO , Prospects in Pharmaceutical Sciences: Tom 15 Nr 10 (2017)
- Katarzyna Kozon, Małgorzata Krzyżanowska, Jakub Olszewski, Andrzej Patyra, Spinal muscular atrophy – the effectiveness of treatment and new therapeutic possibilities for selected groups of patients in Poland , Prospects in Pharmaceutical Sciences: Tom 21 Nr 2 (2023)
- Katarzyna Łysiak, Anna Łysiak, Barbara Maziarz, Paulina Przywara, Natalia Bogumiłło, Kinga Ściurka, Julia Ignacak, Mikołaj Borek, The use of botulinum toxin in ophthalmology , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)
- Małgorzata Krzyżanowska, Katarzyna Kozon, Jakub Olszewski, Andrzej Patyra, Efficacy of satralizumab therapy in the treatment of NMOSD , Prospects in Pharmaceutical Sciences: Tom 21 Nr 3 (2023)
Możesz również Rozpocznij zaawansowane wyszukiwanie podobieństw dla tego artykułu.
Szczegóły
Bibliografia
Statystyki
Autorzy
Zasady cytowania
Cited by / Share
Licencja
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa 4.0 Międzynarodowe.